118 related articles for article (PubMed ID: 2391447)
1. Immunogold labeling of the low-affinity (55 kd) IL2 receptor on the surface of IL2 receptor-bearing cultured cells and mitogen-activated peripheral blood lymphocytes.
McGroarty RJ; Mills GB; de Harven E
J Leukoc Biol; 1990 Sep; 48(3):213-9. PubMed ID: 2391447
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro.
Lai KN; Leung JC; Lai FM
Pathology; 1991 Jul; 23(3):224-8. PubMed ID: 1838146
[TBL] [Abstract][Full Text] [Related]
3. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
[TBL] [Abstract][Full Text] [Related]
4. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
[TBL] [Abstract][Full Text] [Related]
5. The mouse high affinity IL 2 receptor complex. I. Evidence for a third molecule, the putative gamma-chain, associated with the alpha- and/or beta-chain of the receptor.
Herrmann T; Diamantstein T
Immunobiology; 1987 Sep; 175(3):145-58. PubMed ID: 3119468
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 2-induced tyrosine phosphorylation. Interleukin 2 receptor beta is tyrosine phosphorylated.
Mills GB; May C; McGill M; Fung M; Baker M; Sutherland R; Greene WC
J Biol Chem; 1990 Feb; 265(6):3561-7. PubMed ID: 2303462
[TBL] [Abstract][Full Text] [Related]
7. Both the alpha and beta chains of high-affinity interleukin 2 receptors are located in intracellular vesicles when their ligand is endocytosed.
Ferrer M; Hémar A; Duprez V; Hellio R; Dautry-Varsat A
Eur J Cell Biol; 1993 Apr; 60(2):276-82. PubMed ID: 8330625
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes.
Prince HE; John JK
Immunol Invest; 1986 Aug; 15(5):463-72. PubMed ID: 3096881
[TBL] [Abstract][Full Text] [Related]
9. How interleukin-2 can affect human fibroblasts behaviour.
Plaisance S; Alileche A; Han D; Rubinstein E; Sahraoui Y; Jasmin C; Azzarone B
Pathol Res Pract; 1994 Oct; 190(9-10):942-9. PubMed ID: 7899144
[TBL] [Abstract][Full Text] [Related]
10. Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sites.
Le Mauff B; Gascan H; Olive D; Moreau JF; Mawas C; Soulillou JP; Jacques Y
Hum Immunol; 1987 May; 19(1):53-68. PubMed ID: 3034838
[TBL] [Abstract][Full Text] [Related]
11. Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2.
Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Falk RE; Peters WJ
J Trauma; 1987 Feb; 27(2):180-7. PubMed ID: 3102753
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin 2 receptors released from mitogen stimulated human peripheral blood lymphocytes bind interleukin 2 and inhibit IL2 dependent cell proliferation.
Chopra RK; Powers DC; Kendig NE; Adler WH; Nagel JE
Immunol Invest; 1989 Oct; 18(8):961-73. PubMed ID: 2583751
[TBL] [Abstract][Full Text] [Related]
13. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.
Reed JC; Alpers JD; Nowell PC; Hoover RG
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3982-6. PubMed ID: 3012540
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
16. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors.
Nagel JE; Chopra RK; Chrest FJ; McCoy MT; Schneider EL; Holbrook NJ; Adler WH
J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423
[TBL] [Abstract][Full Text] [Related]
17. A study on OX39, a murine anti-rat interleukin 2 receptor antibody. A report on receptor binding and effects on allograft survival.
Jacques Y; Paineau J; Chevalier S; Le Mauff B; Soulillou JP
Transpl Int; 1988 Jul; 1(2):58-63. PubMed ID: 3076381
[TBL] [Abstract][Full Text] [Related]
18. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
[TBL] [Abstract][Full Text] [Related]
19. T lymphocyte activation in euthyroid Graves' ophthalmopathy: soluble interleukin 2 receptor release, cellular interleukin 2 receptor expression and interleukin 2 production.
Lai KN; Leung JC; Chow CC; Cockram CS
Acta Endocrinol (Copenh); 1989 May; 120(5):602-9. PubMed ID: 2786308
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 2 production and interleukin 2 receptor expression by human immature leukemic T cells.
Sahraoui Y; Allouche M; Ammar A; Spanakis E; Clemenceau C; Jasmin C; Perraki M; Varela-Millot C; Georgoulias V
Leukemia; 1992 Oct; 6(10):1025-35. PubMed ID: 1405755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
